HRs for HL from multivariable models
| . | Adjusted HR (95% CI) . | ||
|---|---|---|---|
| Model 1 . | Model 2 . | Model 3 . | |
| Time-updated CD4 count, cells/μL | |||
| < 50 | 1 | — | 1 |
| 50-99 | 0.71 (0.19–2.67) | — | 0.89 (0.22–3.59) |
| 100-199 | 0.80 (0.29–2.23) | — | 0.99 (0.31–3.10) |
| 200-349 | 0.50 (0.18–1.35) | — | 0.57 (0.18–1.79) |
| At least 350 | 0.21 (0.08–0.59) | — | 0.27 (0.08–0.86) |
| Time-update HIV-1 RNA, copies/mL | |||
| ≥ 100 000 | — | 1 | 1 |
| 10 000-99 999 | — | 1.63 (0.64–4.16) | 2.06 (0.79–5.36) |
| 501-9999 | — | 1.13 (0.41–3.06) | 1.54 (0.55–4.32) |
| ≤ 500 | — | 0.67 (0.27–1.63) | 0.98 (0.38–2.50) |
| . | Adjusted HR (95% CI) . | ||
|---|---|---|---|
| Model 1 . | Model 2 . | Model 3 . | |
| Time-updated CD4 count, cells/μL | |||
| < 50 | 1 | — | 1 |
| 50-99 | 0.71 (0.19–2.67) | — | 0.89 (0.22–3.59) |
| 100-199 | 0.80 (0.29–2.23) | — | 0.99 (0.31–3.10) |
| 200-349 | 0.50 (0.18–1.35) | — | 0.57 (0.18–1.79) |
| At least 350 | 0.21 (0.08–0.59) | — | 0.27 (0.08–0.86) |
| Time-update HIV-1 RNA, copies/mL | |||
| ≥ 100 000 | — | 1 | 1 |
| 10 000-99 999 | — | 1.63 (0.64–4.16) | 2.06 (0.79–5.36) |
| 501-9999 | — | 1.13 (0.41–3.06) | 1.54 (0.55–4.32) |
| ≤ 500 | — | 0.67 (0.27–1.63) | 0.98 (0.38–2.50) |
All models include patients before and after starting cART and adjusted for age, sex, transmission group, and CDC clinical stage. Model 1 additionally includes time-updated CD4 count, model 2 additionally includes time-updated HIV-1 RNA, and model 3 includes both time-updated CD4 count and HIV-1 RNA in addition to the baseline variables.
— indicates not applicable.